CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 74 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q2 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $668,000 | -73.6% | 2,650 | -44.4% | 0.00% | -100.0% |
| Q1 2022 | $2,533,000 | -13.7% | 4,766 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $2,934,000 | -39.6% | 4,766 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $4,861,000 | -35.9% | 4,766 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $7,578,000 | -19.3% | 4,766 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $9,389,000 | +57.6% | 4,766 | 0.0% | 0.00% | +50.0% |
| Q4 2020 | $5,957,000 | -30.6% | 4,766 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $8,578,000 | -78.5% | 4,766 | 0.0% | 0.00% | -81.8% |
| Q2 2020 | $39,984,000 | +60.1% | 4,766 | 0.0% | 0.01% | +57.1% |
| Q1 2020 | $24,973,000 | -24.6% | 4,766 | 0.0% | 0.01% | +16.7% |
| Q4 2019 | $33,113,000 | -77.9% | 4,766 | -84.5% | 0.01% | -77.8% |
| Q3 2019 | $149,539,000 | -39.2% | 30,712 | -13.5% | 0.03% | -37.2% |
| Q2 2019 | $245,934,000 | – | 35,502 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $6,307,000 | 4.30% |
| ETF MANAGERS GROUP, LLC | 8,103,641 | $10,130,000 | 0.22% |
| AdvisorShares Investments LLC | 271,873 | $340,000 | 0.08% |
| Platform Technology Partners | 60,000 | $75,000 | 0.04% |
| PINNACLE ASSOCIATES LTD | 942,079 | $1,178,000 | 0.02% |
| HRT FINANCIAL LP | 883,510 | $1,104,000 | 0.02% |
| Virtu Financial LLC | 153,908 | $192,000 | 0.02% |
| Tekla Capital Management LLC | 413,481 | $517,000 | 0.02% |
| Aries Wealth Management | 23,400 | $33,000 | 0.02% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 56,932 | $71,000 | 0.02% |